Harvard Mental Health Letter

In brief: A new sleeping pill

A new type of sleep medication, ramelteon, was approved in 2005 by the FDA. It acts on the receptors for melatonin, which contributes to regulating the body's circadian rhythms.
To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »